ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CO Global Cord Blood Corporation

2.9876
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Global Cord Blood Corporation NYSE:CO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.9876 0 01:00:00

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

03/03/2023 9:20pm

Edgar (US Regulatory)


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of March 2023
 
Commission File Number: 001-34541
 
GLOBAL CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
 
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 
 
Introductory Note
 
On September 22, 2022, the Grand Court of the Cayman Islands (the “Court”) issued an order appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as joint provisional liquidators (the “JPLs”) of Global Cord Blood Corporation (the “Company”) pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands.

Global Cord Blood Corporation JPLs’ Third Report
 
On March 1, 2023, the JPLs furnished their third report (the “Third Report”) to the Court. A copy of the Third Report is available on the Company's website: https://ir.globalcordbloodcorporation.com/static-files/GCBC_Report_1_March_2023.pdf as well as on the JPLs’ estate portal: https://docs.grantthornton.ca/document-folder/viewer/docul8LWsxcWho7J/134017383310188837?_gl=1*1qsum31*_ga*MTk4OTM5NTcwOC4xNjc1NzAwMjI0*_ga_JLRBBJ6PTP*MTY3Nzc2OTAxMy4zLjAuMTY3Nzc2OTAxMy42MC4wLjA.&_ga=2.158998713.2045496885.1677769013-1989395708.1675700224.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GLOBAL CORD BLOOD CORPORATION
 
 
 
 
By:
/s/ John Royle
 
Name: 
John Royle
 
Title:
Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands
 
Dated: March 3, 2023
 
 
 

1 Year Global Cord Blood Chart

1 Year Global Cord Blood Chart

1 Month Global Cord Blood Chart

1 Month Global Cord Blood Chart